Neos Therapeutics to consider other offers after PDL snub: sources

(Reuters) - U.S. drugmaker Neos Therapeutics Inc, which this week rejected a fourth takeover offer by PDL Biopharma Inc, will consider offers from other potential buyers, according to people familiar with the matter.